111 related articles for article (PubMed ID: 16705091)
1. Fine mapping of quantitative trait nucleotides underlying thrombin-activatable fibrinolysis inhibitor antigen levels by a transethnic study.
Frère C; Tregouet DA; Morange PE; Saut N; Kouassi D; Juhan-Vague I; Tiret L; Alessi MC
Blood; 2006 Sep; 108(5):1562-8. PubMed ID: 16705091
[TBL] [Abstract][Full Text] [Related]
2. Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled.
Henry M; Aubert H; Morange PE; Nanni I; Alessi MC; Tiret L; Juhan-Vague I
Blood; 2001 Apr; 97(7):2053-8. PubMed ID: 11264171
[TBL] [Abstract][Full Text] [Related]
3. Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms.
Trégouet DA; Aubert H; Henry M; Morange P; Visvikis S; Juhan-Vague I; Tiret L
Hum Genet; 2001 Aug; 109(2):191-7. PubMed ID: 11511925
[TBL] [Abstract][Full Text] [Related]
4. The impact of single nucleotide polymorphisms of the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI antigen levels in healthy children and pediatric oncology patients.
Knoefler R; Ludwig K; Kostka H; Kuhlisch E; Siegert G; Suttorp M
Semin Thromb Hemost; 2003 Dec; 29(6):575-83. PubMed ID: 14719174
[TBL] [Abstract][Full Text] [Related]
5. Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis.
Boffa MB; Maret D; Hamill JD; Bastajian N; Crainich P; Jenny NS; Tang Z; Macy EM; Tracy RP; Franco RF; Nesheim ME; Koschinsky ML
Blood; 2008 Jan; 111(1):183-9. PubMed ID: 17855631
[TBL] [Abstract][Full Text] [Related]
6. TAFI gene polymorphisms in patients with cerebral venous thrombosis.
Tokgoz S; Zamani AG; Durakbasi-Dursun HG; Yilmaz O; Ilhan N; Demirel S; Tavli M; Sinan A
Acta Neurol Belg; 2013 Sep; 113(3):291-7. PubMed ID: 23264082
[TBL] [Abstract][Full Text] [Related]
7. Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe.
Juhan-Vague I; Morange PE; Aubert H; Henry M; Aillaud MF; Alessi MC; Samnegård A; Hawe E; Yudkin J; Margaglione M; Di Minno G; Hamsten A; Humphries SE;
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):867-73. PubMed ID: 12006404
[TBL] [Abstract][Full Text] [Related]
8. Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.
Franco RF; Fagundes MG; Meijers JC; Reitsma PH; Lourenço D; Morelli V; Maffei FH; Ferrari IC; Piccinato CE; Silva WA; Zago MA
Haematologica; 2001 May; 86(5):510-7. PubMed ID: 11410415
[TBL] [Abstract][Full Text] [Related]
9. A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.
Stanne TM; Olsson M; Lorentzen E; Pedersen A; Gummesson A; Gils A; Jood K; Engström G; Melander O; Declerck PJ; Jern C
Thromb Haemost; 2018 Feb; 118(2):298-308. PubMed ID: 29378355
[TBL] [Abstract][Full Text] [Related]
10. Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy.
Akinci B; Demir T; Saygili S; Yener S; Alacacioglu I; Saygili F; Bayraktar F; Yesil S
Diabetes Res Clin Pract; 2008 Jul; 81(1):93-6. PubMed ID: 18406001
[TBL] [Abstract][Full Text] [Related]
11. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
[TBL] [Abstract][Full Text] [Related]
12. Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
Komnenov D; Scipione CA; Bazzi ZA; Garabon JJ; Koschinsky ML; Boffa MB
Thromb Haemost; 2015 Aug; 114(2):337-49. PubMed ID: 26062599
[TBL] [Abstract][Full Text] [Related]
13. Genetic Polymorphisms Associated with Thrombotic Disease Comparison of Two Territories: Myocardial Infarction and Ischemic Stroke.
Isordia-Salas I; Martínez-Marino M; Alberti-Minutti P; Ricardo-Moreno MT; Castro-Calvo R; Santiago-Germán D; Alvarado-Moreno JA; Calleja-Carreño C; Hernández-Juárez J; Leaños-Miranda A; Majluf-Cruz A
Dis Markers; 2019; 2019():3745735. PubMed ID: 31781299
[TBL] [Abstract][Full Text] [Related]
14. A locus on chromosome 13 influences levels of TAFI antigen in healthy Mexican Americans.
Warren DM; Cole SA; Dyer TD; Soria JM; Souto JC; Fontcuberta J; Blangero J; Maccluer JW; Almasy L
Hum Biol; 2006 Jun; 78(3):329-39. PubMed ID: 17216805
[TBL] [Abstract][Full Text] [Related]
15. Thrombin activatable fibrinolysis inhibitor gene polymorphisms are associated with antigenic levels in the Asian-Indian population but may not be a risk for stroke.
Biswas A; Tiwari AK; Ranjan R; Meena A; Akhter MS; Yadav BK; Behari M; Saxena R
Br J Haematol; 2008 Nov; 143(4):581-8. PubMed ID: 18986391
[TBL] [Abstract][Full Text] [Related]
16. Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition.
Takada K; Seike T; Sasaki T; Masuda Y; Ito A; Ishii H
Thromb Haemost; 2013 Jun; 109(6):1060-9. PubMed ID: 23572161
[TBL] [Abstract][Full Text] [Related]
17. Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE).
McKenzie CA; Abecasis GR; Keavney B; Forrester T; Ratcliffe PJ; Julier C; Connell JM; Bennett F; McFarlane-Anderson N; Lathrop GM; Cardon LR
Hum Mol Genet; 2001 May; 10(10):1077-84. PubMed ID: 11331618
[TBL] [Abstract][Full Text] [Related]
18. Verification of Candidate SNP Effects Reveals Two QTLs on BTA7 for Beef Marbling in Two Japanese Black Cattle Populations.
Sasazaki S; Yamamoto R; Toyomoto S; Kondo H; Akiyama T; Kohama N; Yoshida E; Kawaguchi F; Oyama K; Mannen H
Genes (Basel); 2022 Jul; 13(7):. PubMed ID: 35885973
[TBL] [Abstract][Full Text] [Related]
19. NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations.
Chapman SJ; Khor CC; Vannberg FO; Rautanen A; Segal S; Moore CE; Davies RJ; Day NP; Peshu N; Crook DW; Berkley JA; Williams TN; Scott JA; Hill AV
Genes Immun; 2010 Jun; 11(4):319-25. PubMed ID: 19798075
[TBL] [Abstract][Full Text] [Related]
20. On the use of phylogeny-based tests to detect association between quantitative traits and haplotypes.
Bardel C; Danjean V; Morange P; Génin E; Darlu P
Genet Epidemiol; 2009 Dec; 33(8):729-39. PubMed ID: 19399905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
